IPEG - International Pharmaco EEG Society

 

The 19th biennial IPEG Meeting will be held in NIJMEGEN, The NETHERLANDS

 

from 26th to 30th October 2016

 

 

PRELIMINARY PROGRAM

 

SUBMIT YOUR ABSTRACT NOW, DEADLINE JULY 31ST, 2016

 

REGISTER NOW

 

IPEG EEG Training Course at 26th October 2016 in Nijmegen

 

Read More

 

 

 

The IPEG is a professional association for scientists and researchers actively involved in electrophysiological brain research in preclinical and clinical pharmacology, neurotoxicology, personalized medicine and related areas of interest.


The acronym IPEG stands for International Pharmaco-EEG Society and the IPEG was established in 1980 (history). IPEG members include active members, junior and senior members, corporate members and honorary members. For membership details and becoming a member please go to the subscription page

 

The IPEG has been organizing biennial meetings since its conception in 1980. The last meetings were in Leipzig (Germany - 2014)New York (USA – 2012), Prague (Czech Republic - 2010), Rouffach (France - 2008), Awaji (Japan - 2006), Antwerp (Belgium - 2004) and Barcelona (Spain - 2002).

 

 

  See Impressions from the last Meeting in Leipzig, Germany 2014

 

 The abstract book for the IPEG 2014 meeting in Leipzig can be downloaded here.

 

 The abstract book for the IPEG 2012 meeting in New York can be downloaded here.

 

 

Consider becoming an IPEG Member? See our updated membership application page.

 

 Visitors:

 


Besucherzaehler

 

 

News



Questioning the validity of fMRI studies

A recently published study found up to 70% false-positive results instead of the 5% expected errors in a collection of 499 resting state fMRI data after conducting millions of  random group analyses using the most famous fMRI - Analysis software packages.

...
Read more

Machine Learning and Validation Datasets

Machine Learning is in the rise, also in pharmaco-EEG Research. Reliable Validation data is crucial for these approaches.

...
Read more

Psilocybin in the treatment of Depression

Open-Label Trial with Evidence of Efficiancy of Psylocibin in the Treatment of Depression

...
Read more